Board of Directors

Andrew Sandham, (Chairman)
Lawrence Bloch, MD, JD
Aaron Davidson
Kenneth Galbraith
Jonathan R. Goodman
Richard Meadows
Deepa Pakianathan, PhD
Samuel P. Wertheimer, PhD

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board

Andrew P Sandham, BSc DipM, Chairman & Chief Executive Officer of Kymab, Ltd.

Mr Sandham has 30 years experience in business development and marketing within the healthcare sector. He has played a key role in building successful businesses in pharmaceutical discovery and development in Europe and the USA, serving as a founder and executive of Cantab Pharmaceuticals, Hexagen, Signature BioScience and Ionix Pharmaceuticals. Mr Sandham holds a BSc in Chemistry from UEA, Norwich and a Diploma in Marketing from Chartered Institute of Marketing, UK.